"However, when combined with symptoms consistent with COVID-19 like a fever, cough, and sore throat, a positive test is pretty much diagnostic for the illness," said Jeng, "That is how these rapid serology tests are being used in China." Scanwell's serological test is not a treatment

Key Highlights: Primary endpoint met: ~1.72.0% A1C reduction at 40 weeks vs ~0.8% placebo Significant weight loss: ~1517% reduction vs ~2.5% placebo Sustained efficacy: No weight-loss plateau observed over study duration Triple mechanism: Targets GLP-1, GIP & glucagon receptors for amplified metabolic effects Convenient dosing: Once-weekly injectable therapy Why It Matters: Beyond GLP-1: Signals the shift to multi-hormone incretin therapies Dual efficacy: Combines deep A1C reduction + substantial weight loss Competitive edge: Strengthens Lillys position vs semaglutide & tirzepatide Holistic impact: Potential to improve broader cardiometabolic outcomes Key Takeaway: Retatrutide is emerging as a potential best-in-class metabolic therapy, combining powerful glucose lowering with significant weight loss
B12 IV infusions combine B12 with hydrating fluids and complementary micronutrients, offering near-complete bioavailability and broader physiological support
[DOI] [PubMed] [Google Scholar] 169.Alves R.A., Shao A
How long does shipping take within Australia